The bone-strengthening drug zoledronic acid (Zometa) can help fight metastatic breast cancer when given before surgery, new research suggests. When the drug was given along with chemotherapy for three months before breast cancer surgery, it reduced the number of women who had tumor cells in their bone marrow at the time of surgery.